You are here

Humira

7 companies are rolling out Humira biosimilars

Drugstore News

Wed, 07/12/23 - 09:44 am

Boehringer Ingelheim

Samsung Bioepsis

Coherus Biosciences

Mark Cuban's online pharmacy set to launch Humira biosimilar

Reuters

Fri, 07/7/23 - 06:53 am

Mark Cuban Cost Plus Drugs

Coherus Biosciences

Alvotech to raise cash after third FDA rejection for Humira biosimilar

BioPharma Dive

Fri, 06/30/23 - 11:39 am

Teva Pharmaceutical

Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends

Fierce Pharma

Thu, 06/15/23 - 06:55 pm

Mark Cuban Cost Plus Drugs

Coherus Biosciences

Mark Cuban online pharmacy to offer AbbVie Humira biosimilar

Seeking Alpha

Thu, 06/1/23 - 11:29 am

Coherus Biosciences

Mark Cuban Cost Plus Drugs

AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3

Fierce Pharma

Wed, 05/31/23 - 11:06 am

systemic lupus erythematosus

clinical trials

AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease

Fierce Pharma

Thu, 05/18/23 - 08:36 pm

Crohn's Disease

Where Will AbbVie Be in 5 Years?

Motley Fool

Mon, 05/1/23 - 11:09 am

As Humira biosims take hold, longtime AbbVie CEO Richard Gonzalez talks succession plans

Fierce Pharma

Thu, 04/27/23 - 11:02 pm

Richard Gonzalez

Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA

Business Insider

Mon, 04/17/23 - 11:06 pm

Teva Pharmaceutical

FDA rejects Teva’s high-potency biosimilar of Humira again

Pharmaphorum

Fri, 04/14/23 - 10:37 am

Teva Pharmaceutical

In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog

Fierce Pharma

Tue, 04/11/23 - 10:04 am

hidradenitis suppurativa

Spotlight – following Humira in hidradenitis suppurativa

EP Vantage

Tue, 04/4/23 - 10:10 am

hidradenitis suppurativa

MoonLake Immunotherapeutics

AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa

EP Vantage

Tue, 03/21/23 - 09:54 am

hidradenitis suppurativa

AbbVie's Humira, 5 Pfizer drugs among those with price hikes that exceeded inflation rate

Fierce Pharma

Wed, 03/15/23 - 11:25 am

AbbVie braces for 'greater erosion' of Humira franchise in second half of this year

Endpoints

Tue, 03/7/23 - 10:22 pm

AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff

Fierce Pharma

Tue, 03/7/23 - 11:55 am

Richard Gonzalez

Could This Humira Biosimilar Be a Winner for Amgen?

Motley Fool

Fri, 03/3/23 - 11:48 am

Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’

BioPharma Dive

Tue, 02/21/23 - 11:05 am

Bristol Myers Squibb

Years after the first US biosim launches, doctors still have their concerns: survey

Fierce Pharma

Thu, 02/16/23 - 04:49 pm

Pages